David Bechard

Title: David Bechard: Innovator in Immunocytokine Development

Introduction

David Bechard is a notable inventor based in Saint-Etienne de Montluc, France. He has made significant contributions to the field of immunocytokines, holding a total of 9 patents. His work focuses on the development of innovative methods and compositions that enhance therapeutic applications.

Latest Patents

Among his latest patents is a method for purifying IL-15/IL-15Ralpha based conjugates. This invention relates to preparing a composition that includes monomeric conjugates from a sample. The conjugate comprises a polypeptide with the amino acid sequence of interleukin 15 and a polypeptide with the amino acid sequence of the sushi domain of IL-15Rα. The method utilizes anion-exchange chromatography followed by hydrophobic interaction chromatography. Another significant patent involves IL-15 and IL-15Rα sushi domain based immunocytokines. This invention describes an immunocytokine that includes a conjugate and an antibody or a fragment thereof, which is covalently linked to the conjugate.

Career Highlights

David Bechard has worked with prominent organizations such as Cytune Pharma and the Institut National De La Santé Et De La Recherche Médicale. His experience in these institutions has contributed to his expertise in the field of immunology and biotechnology.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Sebastien Daniel Morisseau and Geraldine Teppaz. These partnerships have fostered innovation and advancement in his research endeavors.

Conclusion

David Bechard is a distinguished inventor whose work in immunocytokines has led to significant advancements in therapeutic methods. His contributions continue to impact the field positively, showcasing the importance of innovation in medical research.